aglatimagene besadenovec
candel therapeutics
['sclc', 'can-2409', 'nsclc']
 presents on can-2409, a replication-deficient adenoviral gene construct, for patients with stage iii/iv #nsclc whose disease was progressing on #antipd1 immune #checkpointinhibitor therapy: #asco22 
We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.